The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Synergy Satellite: Targeted drugs – scattered goals (sponsored by a grant from Novartis)
Affiliation
Heidelberg University Hospital, Pharmacy Department - Deputy Head Pharmacist
Country
Germany
1. Current Status, Position
Dr. Tilman Schöning is currently Deputy Head of Pharmacy at Heidelberg University Hospital and Head of Oncology Pharmacy unit at the Pharmacy.
2. Education
Dr. Tilman Schöning studied Pharmacy at the University of Heidelberg and became a licensed pharmacist in 2020. In 2004 he became specialist in hospital pharmacy. In 2009 he obtained a PhD in medical microbiology for his work on B streptococci.
3. Research Area
Dr. Tilman Schöning focusses on oncology pharmacy in general and on automation in preparation, biosimilar monoclonal antibodies and ATMP in oncology.
4. Conflict of interest
No conflict of interest declared.